ResMed stock sheds 4.11% in mixed market session

6 articles · Updated · MarketWatch · May 1

Shares closed at $205.02 as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones Industrial Average fell 0.31% to 49,499.27.
The stock finished 30.22% below its 52-week high of $293.81, reached on 22 August.
Trading volume reached 3.2 million shares, well above the company's 50-day average of 1.0 million.

ResMed's earnings soared, yet its stock plunged. Are insiders and analysts signaling a deeper problem the market is overlooking?

As its main rival plots a comeback from a massive recall, can ResMed successfully defend the market share it captured?

With blockbuster weight-loss drugs now treating sleep apnea, is ResMed’s market dominance facing an unexpected and formidable threat?